Double-check the serving size
Are there risks to blood pressure when starting GLP-1 therapy
The risks fall into three buckets Common, mild, self-limiting Bruising or soreness at the catheter site Cool sensation along the arm during the drip Warm flush or metallic taste, especially with magnesium or B-complex Mild lightheadedness if the drip runs too fast Uncommon Phlebitis, or vein irritation, especially with stronger or more concentrated formulas Infiltration (fluid leaking under the skin if the catheter shifts) Allergic reactions to specific ingredients, particularly thiamine and B-complex Rare but serious Infection at the IV site Fluid overload in patients with heart, kidney, or liver disease Electrolyte disturbances, especially with high-dose magnesium, potassium, or calcium Red blood cell problems in people with G6PD deficiency, a genetic enzyme issue
The same applies to many rural lower peninsula counties, particularly in the northern half of the state
Fact : According to FDA, a compounded drug might be appropriate if a patients medical need cannot be met by an FDA-approved drug, or the FDA-approved drug is not commercially available
By mimicking these hormones, tirzepatide enhances insulin secretion in a glucose-dependent manner, suppresses inappropriate glucagon release, and slows gastric emptying
